On Tuesday, Anavex Life Sciences Corporation (NASDAQ: AVXL) opened lower -10.78% from the last session, before settling in for the closing price of $8.44. Price fluctuations for AVXL have ranged from $3.51 to $14.44 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -6.85% at the time writing. With a float of $82.55 million, this company’s outstanding shares have now reached $85.33 million.
In an organization with 42 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Anavex Life Sciences Corporation (AVXL) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Anavex Life Sciences Corporation is 3.30%, while institutional ownership is 36.84%. The most recent insider transaction that took place on Jun 14 ’24, was worth 10,319. In this transaction Director of this company bought 2,835 shares at a rate of $3.64, taking the stock ownership to the 5,000 shares.
Anavex Life Sciences Corporation (AVXL) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -6.85% per share during the next fiscal year.
Anavex Life Sciences Corporation (NASDAQ: AVXL) Trading Performance Indicators
Check out the current performance indicators for Anavex Life Sciences Corporation (AVXL). In the past quarter, the stock posted a quick ratio of 6.74.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.56, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach 1.41 in one year’s time.
Technical Analysis of Anavex Life Sciences Corporation (AVXL)
Let’s dig in a bit further. During the last 5-days, its volume was 1.2 million. That was better than the volume of 1.2 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 39.81%. Additionally, its Average True Range was 0.54.
During the past 100 days, Anavex Life Sciences Corporation’s (AVXL) raw stochastic average was set at 5.08%, which indicates a significant decrease from 15.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 66.89% in the past 14 days, which was lower than the 77.18% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.88, while its 200-day Moving Average is $8.02. However, in the short run, Anavex Life Sciences Corporation’s stock first resistance to watch stands at $8.24. Second resistance stands at $8.95. The third major resistance level sits at $9.49. If the price goes on to break the first support level at $6.99, it is likely to go to the next support level at $6.45. Assuming the price breaks the second support level, the third support level stands at $5.74.
Anavex Life Sciences Corporation (NASDAQ: AVXL) Key Stats
There are currently 85,372K shares outstanding in the company with a market cap of 642.85 million. Presently, the company’s annual sales total 0 K according to its annual income of -43,000 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -11,200 K.
